search
Back to results

Cognitive Correlates of Antidepressant Treatment Response in Elders

Primary Purpose

Depression

Status
Completed
Phase
Phase 4
Locations
Canada
Study Type
Interventional
Intervention
Zoloft (antidepressant)
Sponsored by
Unity Health Toronto
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Depression focused on measuring antidepressants, depression, zoloft, psychiatry, psychology

Eligibility Criteria

65 Years - 90 Years (Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • above the age of 65,
  • speak English fluently,
  • experience depression, AND
  • not yet on active treatment.

Exclusion Criteria:

  • active delirium,
  • substance abuse,
  • mental illness other than major depression,
  • active CNS disease,
  • unstable systematic medical disease, OR
  • current of past psychotic disorder.

Sites / Locations

  • St Michael's Hospital

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

zoloft

Arm Description

Both arms of the study will include zoloft. However, the treatment response to zoloft will be compared in two different subgroups.

Outcomes

Primary Outcome Measures

depression

Secondary Outcome Measures

Full Information

First Posted
June 9, 2009
Last Updated
November 18, 2011
Sponsor
Unity Health Toronto
search

1. Study Identification

Unique Protocol Identification Number
NCT01477268
Brief Title
Cognitive Correlates of Antidepressant Treatment Response in Elders
Official Title
Determining the Impact of Dementia and Executive Impairment on Antidepressant Treatment Response in Older Persons
Study Type
Interventional

2. Study Status

Record Verification Date
May 2011
Overall Recruitment Status
Completed
Study Start Date
June 2007 (undefined)
Primary Completion Date
April 2009 (Actual)
Study Completion Date
October 2009 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Unity Health Toronto

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Major depression is a very common health problem affecting older persons. The present standard of treatment is with medications called "antidepressants". Antidepressants have been studied extensively in older persons with normal brain function and have been shown to be effective. However, certain types of brain dysfunction called "executive impairment" (inability to do higher order thinking) may lead to poor treatment outcomes. This study will compare how older depressed people with different levels of executive impairment respond differently to standard antidepressant treatment. Knowing this information will lead to more rational targeting of available treatments, leading to improved treatment outcomes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression
Keywords
antidepressants, depression, zoloft, psychiatry, psychology

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
zoloft
Arm Type
Other
Arm Description
Both arms of the study will include zoloft. However, the treatment response to zoloft will be compared in two different subgroups.
Intervention Type
Drug
Intervention Name(s)
Zoloft (antidepressant)
Other Intervention Name(s)
Sertraline
Intervention Description
Zoloft 50-200 mg po od x 12 weeks
Primary Outcome Measure Information:
Title
depression
Time Frame
June 1, 2007 - June 1, 2008

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: above the age of 65, speak English fluently, experience depression, AND not yet on active treatment. Exclusion Criteria: active delirium, substance abuse, mental illness other than major depression, active CNS disease, unstable systematic medical disease, OR current of past psychotic disorder.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Corinne Fischer, MD
Organizational Affiliation
St. Michaels Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
St Michael's Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5B 1W8
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

Cognitive Correlates of Antidepressant Treatment Response in Elders

We'll reach out to this number within 24 hrs